Showing results (121-130 of 207) with videos related to
Sort By:
Pageof 21
Frontiers in Pharmacology|July 28, 2020
Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) PopulationPraveen Shukla, Srijib Goswami, Ron J Keizer, et al.British Journal of Clinical Pharmacology|June 10, 2000
Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEMT Kerbusch, A D Huitema, J Ouwerkerk, et al.Clinical Pharmacokinetics|January 24, 2019
Personalized Tuberculosis Treatment Through Model-Informed Dosing of RifampicinStijn W van Beek, Rob Ter Heine, Ron J Keizer, et al.Journal of Chromatography|December 2, 1992
Gas chromatographic determination of 2- and 3-dechloroethylifosfamide in plasma and urineG P Kaijser, J H Beijnen, A Bult, et al.Journal of Clinical Pharmacology|January 26, 2011
Model-based evaluation of similarity in pharmacokinetics of two formulations of the blood-derived plasma product c1 esterase inhibitorRon J Keizer, Ilona Kleine Budde, Paul F W Sprengers, et al.Journal of Chromatography|June 24, 1988
Bioanalysis of (E)-5-(2-bromovinyl)-2'-deoxyuridineH J Reeuwijk, H Lingeman, U R Tjaden, et al.Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|June 19, 2017
Superior return to sports rate after patellar tendon autograft over patellar tendon allograft in revision anterior cruciate ligament reconstructionMichèle N J Keizer, Roy A G Hoogeslag, Jos J A M van Raay, et al.Clinical Nuclear Medicine|July 1, 1991
Right ventricle wall motion abnormalities in patients treated with chemotherapyE C Barendswaard, H Prpic, E E Van der Wall, et al.The AAPS Journal|March 10, 2011
Evaluation of α2-integrin expression as a biomarker for tumor growth inhibition for the investigational integrin inhibitor E7820 in preclinical and clinical studiesRon J Keizer, Y Funahashi, T Semba, et al.Journal of Chromatography|May 5, 1993
Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasmaG P Kaijser, J H Beijnen, E L Jeunink, et al.Pageof 21